The untranslated regions within viral segments are the essential promoter elements required for the initiation of viral replication and transcription. The end of the UTR sequence and part of the ORF sequence constitute the packaging signal for progeny viruses. To explore the influence of single-point and multi-site joint mutations in the UTR of the NA gene on the viral expression, we select clones with upregulated expression of the reporter gene and analyze their sequence characteristics. Bioinformatics methods were used to analyze polymorphisms in the untranslated region (UTR) of the neuraminidase gene of the H9N2 influenza A virus. Using the RNA polymerase I reporting system with enhanced green fluorescence protein (EGFP) gene as the reporter gene, libraries containing random mutations at sites within the N2 UTR were constructed using random mutagenesis. The mutants were selected from the randomized mutagenesis libraries for the N2-UTR. The N2-UTR-RNA polymerase I fluorescence reporter system was identified by sequencing and transfected into infected MDCK cells. The expression of the reporter EGFP was observed using fluorescence microscopy, and the relative fluorescence intensity was measured using a multifunctional microplate reader to analyze the expression of the reporter gene (EGFP) qualitatively and quantitatively. Herein, an RNA polymerase reporter system was constructed to rescue the mutated viruses and measure their tissue culture infective dose (TCID50). The results showed that the U13 → C13 mutation in the 3′end of the NA gene promoted the expression of viral RNA and protein, and mutation of other sites within the UTR could differentially regulate viral genomic transcription and translation. These data showed that the U13 → C13 mutation within the variable region of the 3′UTR of the NA gene in the H9N2 influenza virus promotes viral genomic expression and infection.
H9N2 influenza A virus The variable region EGFP N2-UTR RNA polymerase I fluorescence reporter system
This is a preview of subscription content, log in to check access.
This work was supported by the National Natural Science Foundation of China (81871631), the Shenzhen Special Fund Project for Strategic Emerging Industry Development (JCYJ20170306160244540), the Shenzhen Research Project for the Health and Family Planning System (201602002), and the Guangdong Provincial Medical Science and Technology Foundation (A2018269).
Compliance with ethical standards
Conflict of interest
All authors declare that they have no conflicts of interest to disclose.
This article does not contain any studies with human participants or animals that were performed by any of the authors.
Selman M et al (2012) Adaptive mutation in influenza A virus non-structural gene is linked to host switching and induces a novel protein by alternative splicing. Emerg Microbes Infect 1(11):e42PubMedPubMedCentralGoogle Scholar
Wise HM, Barbezange C, Jagger BW et al (2011) Overlapping signals for translational regulation and packaging of influenza A virus segment 2. Nucleic Acids Res 39(7):7775–7790CrossRefPubMedPubMedCentralGoogle Scholar
Wise HM, Foeglein A, Sun J et al (2009) A complicated message: identification of a novel PB1-related protein translated from influenza A virus segment 2 mRNA. J Virol 83(16):8021–8031CrossRefPubMedPubMedCentralGoogle Scholar
Wise HM, Hutchinson EC, Jagger BW et al (2012) Identification of a novel splice variant from of the influenza A virus M2 ion channel with an antigenically distinct ectodomain. PLoS Pathog 8(11):e1002998CrossRefPubMedPubMedCentralGoogle Scholar
Vasin AV, Temkina OA, Egorov VV et al (2014) Molecular mechanisms enhancing the proteome of influenza A virus: an overview of recently discovered proteins. Virus Res 185:53–63CrossRefPubMedGoogle Scholar
Fodor E (2013) The RNA polymerase of influenza a virus:mechanisms of viral transcription and replication. Acta Virol 57(2):113–122CrossRefPubMedGoogle Scholar
Xie Y, Gong J, Li M et al. (2011) The medicinal potential of influenza virus surface proteins: hemagglutinin and neuraminidase. Curr Med Chem 18(7):1050–1066CrossRefPubMedGoogle Scholar
Gong J, Xu W, Zhang J (2007) Structure and functions of influenza virus neuraminidase. Curr Med Chem 14(1):113–122CrossRefPubMedGoogle Scholar
Barman S, Krylov PS, Turner JC et al (2017) Manipulation of neuraminidase packaging signals and hemagglutinin residues improves the growth of A/Anhui/1/2013 (H7N9) influenza vaccine virus yield in eggs. Vaccine 35(10):1424–1430CrossRefPubMedGoogle Scholar
de Wit E, Spronken MI, Rimmelzwaan GF et al (2006) Evidence for specific packaging of the influenza A virus genome from conditionally defective virus particles lacking a polymerase gene. Vaccine 24(44–46):6647–6650Google Scholar
Zhao L, Peng Y, Zhou K et al (2014) New insights into the nonconserved noncoding region of the subtype-determiant hemagglutinin and neuraminidase segments of influenza A viruses. J Virol 88(19):11493–11503CrossRefPubMedPubMedCentralGoogle Scholar
Wei Sun J, Li P, Han et al (2014) U4 at the 3′ UTR of PB1 segment of H5N1 influenza virus promotes RNA polymerase activity and contributes to viral pathogenicity. Plos ONE 9(3):e93366CrossRefPubMedGoogle Scholar
Lee KH, Seong BL (1998) The position 4 nucleotide at the 3′ end of the influenza virus neuraminidase vRNA is involved in temporal regulation of transcription and replication of neuraminidase RNAs and affects the repertoire of influenza virus surface antigens. J Gen Virol 79(8):1923–1934CrossRefPubMedGoogle Scholar
Hoffmann E, Neumann G, Kawaoka Y et al (2000) A DNA transfection system for generation of influenza A virus from eight plasmids. Proc Natl Acad Sci 97(11):6108–6113Google Scholar
Peng J, Zhang D, Ma Y et al (2014) Protective effect of fluvastain on influenza virus infection. Mol Med Rep 9(6):2221–2226CrossRefPubMedGoogle Scholar
Kobayashi Y, Dadonaite B, van Doremalen N et al (2016) Computational and molecular analysis of conserved influenza A virus RNA secondary structures involved in infectious virion production. RNA Biol 13(9):883–894CrossRefPubMedPubMedCentralGoogle Scholar
Ma J, Liu K, Xue C et al (2013) Impact of the segment-specific region of the 3′-untranslated region of the influenza A virus PB1 segment on protein expression. Virus Genes 47(3):429–438CrossRefPubMedGoogle Scholar
Fodor E, Palese P, Brownlee GG et al (1998) Attenuation of influenza A virus mRNA levels by promoter mutations. J Virol 72(8):6283–6290PubMedPubMedCentralGoogle Scholar
Lee MK, Bae SH, Park CJ et al (2003) A single-nucleotide natural variation (U4 to C4) in an influenza A virus promoter exhibits a large structural change: implications for differential viral RNA synthesis by RNA-dependent RNA polymerase. Nucleic Acids Res 31(4):1216–1223CrossRefPubMedPubMedCentralGoogle Scholar
Ng SS, Li OT, Cheung TK et al (2008) Heterologous influenza vRNA segments with identical non-coding sequences stimulate viral RNA replication in trans. Virol J 11:5:2CrossRefGoogle Scholar
Crescenzo-Chaigne B, Barbezange C, van der Werf S (2008) Non coding extremities of the seven influenza virus type C vRNA segments: effect on transcription and replication by the type C and type A polymerase complexes. J Virol 5:132CrossRefGoogle Scholar
Hutchinson EC, Von Kirchbach JC, Gog JR et al (2010) Genome packaging in influenza A virus. J Gen Virol 91(2):313–328CrossRefPubMedGoogle Scholar